1. Home
  2. APC vs QURE Comparison

APC vs QURE Comparison

Compare APC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APC

ARKO Petroleum Corp. Class A Common Stock

N/A

Current Price

$18.57

Market Cap

920.0M

Sector

Energy

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$46.70

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APC
QURE
Founded
2025
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
920.0M
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
APC
QURE
Price
$18.57
$46.70
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$21.75
$45.00
AVG Volume (30 Days)
118.7K
2.0M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
10.99%
N/A
EPS Growth
N/A
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$4.47
$126.12
Revenue Next Year
$4.20
$200.43
P/E Ratio
$25.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.08
$8.73
52 Week High
$21.72
$71.50

Technical Indicators

Market Signals
Indicator
APC
QURE
Relative Strength Index (RSI) 37.18 79.16
Support Level $17.43 $21.63
Resistance Level $19.43 $60.70
Average True Range (ATR) 1.02 2.43
MACD -0.18 1.72
Stochastic Oscillator 7.12 84.49

Price Performance

Historical Comparison
APC
QURE

About APC ARKO Petroleum Corp. Class A Common Stock

Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: